RYTM
Rhythm Pharmaceuticals, Inc.Company with tickers: RYTM
Market Cap
$7.37B
Shares Outstanding
68,532,607
CIK
1649904
CUSIP
76243J105
13F Activity (30d)
5 filings
3 filers
Website
Visit website
Investor Relations
Investor relations
Press releases and events scraped from the company's investor relations website. News and event listings link back to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-06-13 | Results from Phase 2 Trial Evaluating Setmelanotide in PWS at Six Months | Event |